MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular ...

本研究针对ICU中呼吸机相关肺炎(VAP)和院内获得性肺炎(vHAP)患者，通过前瞻性评估FilmArray? Pneumonia+ panel(FA-PP)在抗生素治疗期间的病原体载量动态变化，发现尽管FA-PP与传统培养的定量结果均随时间显著下降(p0.0001)，但两者均未能预测临床成功率(60.2%)。该多中心 ...

Idaho Technology, Inc. announced the European launch of its FilmArray Respiratory Panel (FilmArray RP), a multiplex clinical diagnostic product that simultaneously detects 21 respiratory pathogens in ...

法国体外诊断公司生物梅里埃今天表示，它已就收购BioFire Diagnostics公司签署了一项协议。收购金额为4.5亿美元外加BioFire的净金融负债。BioFire公司总部位于美国犹他州盐湖城，前身为Idaho Technology。该公司销售FilmArray分子诊断系统及相关的传染病检测产品 法国 ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,394,608 covering the company’s FilmArray ...

Idaho Technology, Inc.,(ITI) a privately held clinical diagnostics company, has received the US Food and Drug Administration (FDA) 510(k) clearance of five additional pathogens for its FilmArray ...

SALT LAKE CITY, UT - Idaho Technology, Inc. (ITI) announced today that the U.S. Food and Drug Administration has issued a 510(k) clearance for the FilmArray instrument and the FilmArray Respiratory ...

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...

On July 28, BioFire sponsored a webinar titled “The Clinical IMPACT of the FilmArray GI Panel.” The webinar featured Kimberle Chapin, MD, DABMM, FCAP, Director of Microbiology and ID Molecular ...